株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

下大静脈フィルター (IVCF) :パイプライン製品の分析

Inferior Vena Cava Filters (IVCF) - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 333942
出版日 ページ情報 英文 37 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.37円で換算しております。
Back to Top
下大静脈フィルター (IVCF) :パイプライン製品の分析 Inferior Vena Cava Filters (IVCF) - Medical Devices Pipeline Assessment, 2017
出版日: 2017年03月16日 ページ情報: 英文 37 Pages
概要

当レポートでは、現在開発中の下大静脈フィルター (IVCF) のパイプライン製品情報について調査分析し、主要製品・プロジェクト、主要企業、治験情報、最近の動向などについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 下大静脈フィルター (IVCF) の概要

第3章 開発中の製品

  • IVCF - パイプライン製品:開発段階別
  • IVCF - パイプライン製品:セグメント別
  • IVCF - パイプライン製品:地域別
  • IVCF - パイプライン製品:規制経路別
  • IVCF - パイプライン製品:承認時期別 (予定)
  • IVCF - 進行中の治験

第4章 下大静脈フィルター (IVCF) :開発中のパイプライン製品 (企業別)

  • IVCF企業 - パイプライン製品:開発段階別
  • IVCF - パイプライン製品:開発段階別

第5章 下大静脈フィルター (IVCF) 企業と製品の概要

  • Adient Medical Inc.
  • Bio2 Medical, Inc.
  • Contego Medical, LLC Company
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • NOvate Medical Technologies
  • Veniti, Inc.
  • Volcano Corporation
  • VueKlar Cardiovascular Ltd.

第6章 下大静脈フィルター (IVCF) :最近の動向

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0310EPD

GlobalData's Medical Devices sector report, "Inferior Vena Cava Filters (IVCF) - Medical Devices Pipeline Assessment, 2017" provides an overview of Inferior Vena Cava Filters (IVCF) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inferior Vena Cava Filters (IVCF) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inferior Vena Cava Filters (IVCF) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Inferior Vena Cava Filters (IVCF) Overview 5

3 Products under Development 6

  • 3.1 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 6
  • 3.2 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Segment 7
  • 3.3 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Territory 8
  • 3.4 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Regulatory Path 9
  • 3.5 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Estimated Approval Date 10

4 Inferior Vena Cava Filters (IVCF) - Pipeline Products under Development by Companies 11

  • 4.1 Inferior Vena Cava Filters (IVCF) Companies - Pipeline Products by Stage of Development 11
  • 4.2 Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 12

5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview 13

  • 5.1 Adient Medical Inc. Company Overview 13
    • 5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 Contego Medical, LLC Company Overview 14
    • 5.2.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.3 Interventional & Surgical Innovations, LLC Company Overview 15
    • 5.3.1 Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.4 Kaleidoscope Company Overview 16
    • 5.4.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.5 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 17
    • 5.5.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.6 Veniti Inc Company Overview 18
    • 5.6.1 Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.7 Volcano Corp Company Overview 19
    • 5.7.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.8 VueKlar Cardiovascular Ltd Company Overview 20
    • 5.8.1 VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

6 Inferior Vena Cava Filters (IVCF)- Recent Developments 22

  • 6.1 Feb 22, 2017: Change in the B. Braun Management Board 22
  • 6.2 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 22
  • 6.3 Jan 26, 2017: Bard Announces Fourth Quarter Results 23
  • 6.4 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 24
  • 6.5 Oct 25, 2016: Bard Announces Third Quarter Results 26
  • 6.6 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 26
  • 6.7 Oct 05, 2016: First Commercial Placements of the Angel Catheter in the United States 27
  • 6.8 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 28
  • 6.9 Aug 24, 2016: Bio2 Medical Announces 510(k) Clearance from the FDA for the Angel Catheter, the First Ever Prophylactic Use Indication for a Medical Device for Pulmonary Embolism 28
  • 6.10 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 29
  • 6.11 Jul 26, 2016: Bard Announces Second Quarter Results 31
  • 6.12 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 32
  • 6.13 Jul 01, 2016: Adient Medical Raises USD1.46 Million in Venture Financing 32
  • 6.14 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 32

7 Appendix 34

  • 7.1 Methodology 34
  • 7.2 About GlobalData 37
  • 7.3 Contact Us 37
  • 7.4 Disclaimer 37

List of Tables

1.1 List of Tables

  • Table 1: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 6
  • Table 2: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Segment 7
  • Table 3: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Territory 8
  • Table 4: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Regulatory Path 9
  • Table 5: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Estimated Approval Date 10
  • Table 6: Inferior Vena Cava Filters (IVCF) Companies - Pipeline Products by Stage of Development 11
  • Table 7: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 12
  • Table 8: Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 9: Absorbable Vascular Filter - Product Status 13
  • Table 10: Absorbable Vascular Filter - Product Description 13
  • Table 11: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • Table 12: Temporary IVC Filter - Product Status 14
  • Table 13: Temporary IVC Filter - Product Description 14
  • Table 14: Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 15: Inferior Vena Cava Filter - Product Status 15
  • Table 16: Inferior Vena Cava Filter - Product Description 15
  • Table 17: Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 18: Reversible IVC Filter - Product Status 16
  • Table 19: Reversible IVC Filter - Product Description 16
  • Table 20: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 21: Second Generation Vena Cava Filter - Product Status 17
  • Table 22: Second Generation Vena Cava Filter - Product Description 17
  • Table 23: Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 24: VENITI VIDI Vena Cava Filter - Product Status 18
  • Table 25: VENITI VIDI Vena Cava Filter - Product Description 18
  • Table 26: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 27: Lumifi - Crux + IVUS Combo - Product Status 19
  • Table 28: Lumifi - Crux + IVUS Combo - Product Description 19
  • Table 29: VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 30: MR-Enhancing Retrievable Vena Cava Filter - Product Status 20
  • Table 31: MR-Enhancing Retrievable Vena Cava Filter - Product Description 21
  • Table 32: Glossary 36

List of Figures

1.2 List of Figures

  • Figure 1: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 6
  • Figure 2: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Segment 7
  • Figure 3: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Territory 8
  • Figure 4: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Regulatory Path 9
  • Figure 5: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Estimated Approval Date 10
Back to Top